๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Diabetic Nephropathy

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors NCT04916132n/a13 sites๐Ÿ“ Skejby๐Ÿ“ Copenhagen๐Ÿ“ Hillerรธd Herlev Hospital ยท Tests: Kidney Biopsy The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy NCT06843304n/a1 site๐Ÿ“ Beijing Chinese PLA General Hospital A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy NCT06661174n/a1 site๐Ÿ“ Beijing China-Japan Friendship Hospital ยท Tests: Bariatric surgery, Non-surgical therapy Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) NCT01802034n/a1 site๐Ÿ“ New York The Rogosin Institute Transformative Research in Diabetic Nephropathy NCT02986984n/a17 sites๐Ÿ“ Little Rock๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto University of Pennsylvania ยท Tests: There is no intervention Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD NCT06110130Phase 41 site๐Ÿ“ Washington D.C. Washington D.C. Veterans Affairs Medical Center ยท Tests: Empagliflozin 10 MG, Placebo Raman Spectroscopy Diagnosis of Kidney Diseases NCT06760845n/a1 site๐Ÿ“ Jinan Zunsong Wang ยท Tests: Imaging Time Lactoferrin Supplementation in Diabetic Nephropathy NCT07764991Phase 21 site๐Ÿ“ Cairo Ain Shams University ยท Tests: Lactoferrin, Antidiabetic, Placebo Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes NCT05822609Phase 24 sites๐Ÿ“ Aurora๐Ÿ“ Seattle๐Ÿ“ Spokane University of Washington ยท Tests: Semaglutide, Placebo Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community NCT05349955NA13 sites๐Ÿ“ Suzhou๐Ÿ“ Suzhou๐Ÿ“ Suzhou Shanghai Zhongshan Hospital ยท Tests: Intensive guideline algorithm implementation, Conventional guideline algorithm implementation Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease NCT06846034NA1 site๐Ÿ“ Poitiers Poitiers University Hospital ยท Tests: Hypoxia administration study group, Renal clairance study Formoterol in Diabetes NCT07022418Phase 21 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Formoterol furmarate (20 ฮผg) Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease NCT06452862n/a1 site๐Ÿ“ Shenyang Shengjing Hospital ยท Tests: Magnetic Resonance Imaging Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes NCT06936670NA2 sites๐Ÿ“ Seattle๐Ÿ“ Seattle Seattle Children's Hospital ยท Tests: Inspiratory Muscle Strength Training (IMST), Sham Training Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care NCT07169422NA1 site๐Ÿ“ Halifax Nova Scotia Health Authority ยท Tests: Usual care for diabetic kidney disease management without primary care provider., Pharmacist-led validated diabetic kidโ€ฆ A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort NCT07024823Phase 15 sites๐Ÿ“ Glendale๐Ÿ“ Chicago๐Ÿ“ Ann Arbor AstraZeneca ยท Tests: AZD4248, Placebo, AZD4248, Placebo NAD Augmentation in Diabetes Kidney Disease NCT05759468Phase 21 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Investigational Product - MIB 626, Placebo Study of WAL0921 in Patients With Glomerular Kidney Diseases NCT06466135Phase 250 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Tamarac Walden Biosciences ยท Tests: WAL0921, Placebo Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy NCT07822152Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: UC-MSCs, Placebo Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes NCT06586203NA2 sites๐Ÿ“ Montreal๐Ÿ“ Montreal Optithera ยท Tests: Polygenic Risk Score Patients With Type 2 Diabetes NCT07245082n/a1 site๐Ÿ“ Taipei National Taiwan University Hospital PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes NCT05390892Phase 436 sites๐Ÿ“ Huntsville๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles Brigham and Women's Hospital ยท Tests: SGLT2 inhibitor, GLP-1 receptor agonist ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases NCT07187713Phase 41 site๐Ÿ“ Giza Ace Cells Lab Limited ยท Tests: ACE Reno Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) NCT05469659Phase 21 site๐Ÿ“ Matsumoto Shinshu University ยท Tests: Tofogliflozin, Metformin Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial NCT07396155Phase 1, Phase 21 site๐Ÿ“ Yogyakarta PT. Prodia Stem Cell Indonesia ยท Tests: Umbilical Cord Mesenchymal Stem Cells Efficacy and Safety Study of Isuzinaxib in Subjects With DKD NCT06962098Phase 220 sites๐Ÿ“ Ansan-si๐Ÿ“ Busan๐Ÿ“ Busan Aptabio Therapeutics, Inc. ยท Tests: Isuzinaxib, Placebo Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy NCT03512132n/a1 site๐Ÿ“ Dijon Centre Hospitalier Universitaire Dijon ยท Tests: Blood samples, Urine sample Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis NCT07010250n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris China Kidney Patient Trials Network NCT05036850n/a1 site๐Ÿ“ Beijing George (Beijing) Clinical Research Co. Ltd. Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD) NCT07434791NA1 site๐Ÿ“ Toronto Sunnybrook Health Sciences Centre ยท Tests: Early goal-directed Cardio-Kidney-Metabolic (CKM) care, Standard care (Comparison arm)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy